Q4 2025 + Q1 2026 (Oct 2025 – Mar 2026) | Source: HubSpot CRM + Grain AI Call Intelligence
Each deal classified by primary loss driver. HubSpot closed_lost_reason + Grain call analysis used for classification.
Controllable vs. uncontrollable: $1.35M (4 deals) was lost to events outside WbD's influence — Metronome acquired by Stripe ($386K), Wiz UK frozen by Google acquisition ($166K), Teknor Apex cancelled internally ($150K), and Confluent acquired by IBM ($100K). The remaining $7.01M spans execution gaps, positioning mismatches, and competitive losses. Some borderline cases (e.g., "went dark" could reflect either weak execution or genuine buyer-side chaos) mean the controllable share likely falls in a 60–85% range. Regardless of the exact figure, the direction is clear: most of this pipeline was addressable.
Methodology note: Loss reasons classified using HubSpot closed_lost_reason field + Grain call analysis. ICP segmentation uses HubSpot enrichment-estimated annual revenue, which may differ from verified ARR. Recommend spot-checking 5 deals for classification accuracy.
Company annual revenue from HubSpot enrichment mapped against defined ICP of $50M–$2B ARR. Note: HubSpot revenue estimates may differ from verified ARR — some values appear inflated (e.g., WP Engine at $10B vs. ~$400M actual). Treat as directional, not precise.
Above-ICP pattern: 10 deals worth $2.04M targeted companies above $2B (Okta, Siemens, Rakuten, DXC, Digital Realty, Check Point, TD SYNNEX). These are enterprise logos where procurement complexity, MEDDIC requirements, and incumbent vendor relationships create structural disadvantages. 4 of the 5 MEDDIC-first losses came from above-ICP companies.
Below-ICP pattern: Lambda Labs ($1M ARR) accounted for $505K across 2 deals. Cerby ($10M) lost $100K. Below-ICP companies may lack the RevOps infrastructure to operationalize methodology at scale — creating both delivery risk and a "stickiness" gap.
ICP targeting implication: If the team had focused exclusively on in-ICP deals, the loss pool shrinks from $8.36M to $3.70M. The remaining $4.66M in out-of-ICP losses represents either deliberate strategic bets (requiring different playbooks) or undisciplined pipeline that inflates reporting without improving win rates.
Named competitors appearing in lost deal reasons. Deals where a specific competitor was cited as the winner.
* NBCUniversal closed Sep 29, 2025 — included for competitive pattern completeness. All other deals within Q4 2025 + Q1 2026.
Patterns from Grain call recordings — what prospects say in their own words during discovery and evaluation.
Prospects consistently distinguish between methodology and training events. They want a system that changes how their team operates daily.
Prospects with existing MEDDIC implementations want SPICED to complement their qualification framework, not compete with it.
The #1 concern across conversations: will this actually change behavior, or will it be another training event?
Advanced prospects see SPICED as a company-wide operating language, not just a sales tool.
Across WbD's own customers' pipelines, Grain reveals a macro shift in buyer behavior that directly mirrors our own loss patterns.
The indecision pattern is self-referential. Our customers' #1 loss reason (status quo / went dark) is also our #1 loss reason ($1.46M). The root cause is the same: insufficient discovery depth, no critical event established, and no quantified impact to justify action. CData's Claude-built dashboard shows that when Impact and Decision fields in SPICED are empty, loss rates spike. This is both a product insight and a sales execution gap.
Pattern: 4 deals worth $720K were lost specifically because prospects required MEDDIC-first positioning. A 5th deal — Darktrace ($500K) — is delayed, not lost, with an active path back via SPICED mid-year execution. In every case, the prospect didn't reject WbD's methodology — they needed MEDDIC and methodology. MEDDIC Powered by SPICED directly addresses this gap. Cerby ($100K) was lost when 1mind partner took the deal solo as a "MEDDIC shop" — even partner deals are affected.
| Company | Amount | What They Said |
|---|---|---|
| JFrog | $400,000 | $500M+ ARR, PLG-to-enterprise shift. "Preferred MEDDIC more central to training than SPICED." |
| Maxar | $250,000 | CTO/CEO hard requirement: "MEDDIC is requirement" — wanted MEDDPICC-first, not overlay. |
| Okta | $250,000 | Deal name was literally "MEDDIC Alignment." Champion not final decision-maker; consensus stalled. |
| Rakuten | $120,000 | "MEDDIC — the CEO wanted a quick win." Existing customer choosing qualification speed over methodology depth. |
| Cerby | $100,000 | "1mind will take solo — they are a MEDDIC shop, and the design element wasn't a strong enough fit." |
Two deals ($437K) cited WbD pricing at approximately 3x competitor quotes. WP Engine ($250K, 500 CS reps, ACV $175K) said "price is about triple." Factorial ($187K, ACV $25K) lost for the third time on price — "3x too expensive." Both are mid-market companies where the cost-per-rep math doesn't work at WbD's current structure. This is a segment mismatch, not a global pricing issue.
Grain data reveals a pattern that extends beyond new business: prospects and customers cite "methodology fatigue" from cycling through frameworks (Challenger → MEDDIC → WbD) without sustained adoption.
This insight is critical for product strategy: the market increasingly expects methodology to be embedded in tools (Salesforce, Gong, Gainsight), not delivered as training events. The Darktrace/Salesforce partnership discussion explicitly explored training Salesforce AI agents on SPICED — this is where the market is heading.
Scope creep tension (from Grain): Causeway/Rothschild explicitly said "we're not looking for full bow tie SPICED soup to nuts — the way in would be this enablement piece." People.ai asked WbD to NOT call SPICED a methodology and present it only as a "framework." The most successful engagements happen when WbD meets customers in their language first — ASCM's Bryan Miller, who deeply understands methodology, was won over precisely because he arrived speaking WbD's language already.
Rachael Smith is no longer active in HubSpot. Her 5 deals ($1.34M) — Contentful, Digital Realty, Lambda Labs (x2), FrontApp — are orphaned. Pipeline ownership needs reassignment for any recovery efforts.
34 deals with adjusted amounts above placeholder threshold. Sorted by loss reason, then value.
| # | Company | Deal | Owner | Amount | Status | Loss Reason | Detail | Link |
|---|---|---|---|---|---|---|---|---|
| Went Dark — 5 deals · $1.46M | ||||||||
| 1 | Digital Realty Trust | Methodology Rollout | Rachael Smith * | $400,000 | Lost | Went Dark | No response post-GTM reorg. Past methodology rollouts stalled — likely internal fatigue. | HS→ |
| 2 | Postman | Methodology Transformation | Dan Smith | $375,000 | Lost | Went Dark | CRO on paternity leave during eval. 700 GTM, $200M+ ARR, 5 vendors. Requirements shifted. | HS→ |
| 3 | Okta | MEDDIC Alignment | Dan Smith | $250,000 | Lost | Went Dark | Champion not final decision-maker. Lengthy consensus cycle stalled — no executive sponsor. | HS→ |
| 4 | Obsidian Security | GTM Efficiency Program | Betsy Peters | $210,000 | Lost | Went Dark | Growth decelerating 3x→2x. GTM efficiency pressure rising but no champion materialized. | HS→ |
| 5 | Siemens | Manager Training | Mike Boogaard | $150,000 | Lost | Went Dark | Gone dark. No response after first email referral from Andrew. | HS→ |
| External Event — 4 deals · $1.35M — Uncontrollable | ||||||||
| 6 | Metronome | Revenue Architecture | Dan Smith | $386,000 | Lost | Acquisition | Acquired by Stripe. All vendor engagements cancelled. | HS→ |
| 7 | Wiz UK | Training | Mike Boogaard | $166,000 | Lost | Acquisition | Google acquisition froze all vendor procurement. Not a competitive loss. | HS→ |
| 8 | Teknor Apex | Mothership Transformation | Betsy Peters | $150,000 | Lost | Cancelled | March project cancelled. 101-year-old manufacturer — sales restructuring never happened. | HS→ |
| 9 | Confluent | Sales Transformation | Dan Smith | $100,000 | Lost | Acquisition | Company acquired by IBM. All vendor evaluations halted. | HS→ |
| MEDDIC-First — 5 deals · $1.22M | ||||||||
| 10 | Darktrace | Methodology Transformation | Matt Kaminski | $500,000 | Delayed | MEDDIC-First | 1,700+ GTM, US IPO prep. Will execute SPICED mid-year, not at SKO. Active path back. | HS→ |
| 11 | JFrog | Enterprise Training | Mike Boogaard | $400,000 | Lost | MEDDIC-First | $500M+ ARR, PLG→enterprise shift. Wanted MEDDPICC more central to training than SPICED. | HS→ |
| 12 | Maxar Technologies | Subscription Model GTM | Dan Smith | $250,000 | Lost | MEDDIC-First | MEDDIC hard requirement from CTO/CEO. Wanted MEDDPICC-first, not methodology overlay. | HS→ |
| 13 | Rakuten | Methodology / MEDDIC vs. SPICED | Dan Smith | $120,000 | Lost | MEDDIC-First | CEO wanted MEDDIC as a "quick win." Existing customer chose qualification speed over methodology depth. | HS→ |
| 14 | Cerby | 1mind / WbD Joint Sales | Dan Smith | $100,000 | Lost | MEDDIC-First | 1mind took solo — MEDDIC shop. WbD design element wasn't a strong enough fit alone. | HS→ |
| Competitor — 4 deals · $1.20M | ||||||||
| 15 | First Advantage | Sales & CS Training | Dan Smith | $500,000 | Lost | Value Selling | Lost to Value Selling — incumbent from acquired Sterling. 551 GTM reps. | HS→ |
| 16 | Contentful | CKO & Quarterly Training | Rachael Smith * | $400,000 | Lost | Sandler | CRO had longstanding Sandler relationship. WbD runner-up of 8 vendors — "ran the best sales cycle." | HS→ |
| 17 | FrontApp | Sales Methodology Rollout | Rachael Smith * | $150,000 | Lost | Sandler | Lost to Sandler. No enablement person for 2 years — budget constraints tipped decision. | HS→ |
| 18 | Dropbox | Manager Coaching | Rachael Smith * | $150,000 | Lost | Competitor | Existing customer. Manager coaching deal did not progress. | HS→ |
| No Priority — 5 deals · $925K | ||||||||
| 19 | McKesson | Growth Strategy Phase 2 | Dan Smith | $220,000 | Lost | No Priority | Phase 2 lacked urgency after Phase 1. No champion driving continued investment. | HS→ |
| 20 | Frontline Education | K-12 Revenue Transformation | Betsy Peters | $190,400 | Lost | No Priority | No critical event. New management — urgency before August slowdown never materialized. | HS→ |
| 21 | Lambda Labs | Right Side Playbook | Rachael Smith * | $155,000 | Lost | No Priority | Post-sale friction consumed bandwidth. Data center financing took priority. | HS→ |
| 22 | Bitso | B2B Payments GTM | Dan Smith | $150,000 | Lost | No Priority | Not priority for sales leadership despite 70% growth. No RevOps team to drive internally. | HS→ |
| 23 | SpaceX | Enablement for Resellers | Dan Smith | $100,000 | Lost | No Priority | EVP doesn't believe skills training will get quick wins for channel partners. | HS→ |
| Rescoping — 3 deals · $650K | ||||||||
| 24 | Lambda Labs | SOW 4 — Coaching | Rachael Smith * | $350,000 | Delayed | Rescoping | Placeholder SOW being rescoped. Lambda pivoting to cloud, targeting $1B ARR. | HS→ |
| 25 | ABC Fitness | Revenue Ops Restructure | Matt Kaminski | $150,000 | Lost | Rescoping | $350M company, 38% onboarding churn. Board couldn't reach consensus on direction. | HS→ |
| 26 | TD SYNNEX | Channel Enablement | Matt Kaminski | $150,000 | Delayed | Rescoping | 3rd-party agent; potential need late Fall. Parked, not dead. | HS→ |
| Champion Left — 3 deals · $460K | ||||||||
| 27 | Cognism | Training | Mike Boogaard | $180,000 | Lost | Champion Left | Champion left, new management. $80M+ SaaS, 120 reps — deal died with leadership change. | HS→ |
| 28 | Tango Analytics | Growth Strategy | Betsy Peters | $150,000 | Lost | Champion Left | Champion left during layoffs (20 cut). Recruiting new CS head — org instability killed momentum. | HS→ |
| 29 | Zafin | SPICED Follow-On | Dan Smith | $130,000 | Lost | Champion Left | DM left for health reasons. New leader not going in this direction. | HS→ |
| Price — 2 deals · $437K | ||||||||
| 30 | WP Engine | Sales Training — SPICED | Dan Smith | $250,000 | Lost | Price | Price ~3x competitor quote. 175K customers, 500 CS reps — wanted SPICED but couldn't justify cost. | HS→ |
| 31 | Factorial | Training (3rd attempt) | Mike Boogaard | $187,000 | Lost | Price | 3rd time WbD lost here. Price 3x too high — ACV only $25K, cost/value mismatch for their scale. | HS→ |
| DIY / Access — 2 deals · $395K | ||||||||
| 32 | Check Point | SKO | Mike Boogaard | $295,000 | Lost | In-House | Decided to do SKO in-house. Building internal enablement capability. | HS→ |
| 33 | DXC Technology | New Deal | Dan Smith | $100,000 | Lost | No Access | Not able to access decision maker. Wanted quote via email without discovery — not a fit. | HS→ |
| Access / Fit — 1 deal · $140K | ||||||||
| 34 | Five9 | Advisory Access Pass — SKO | Matt Kaminski | $140,000 | Lost | Limited Access | Limited access to execs. Existing customer but couldn't progress advisory engagement. | HS→ |
Data Quality Note: An additional ~90 deals in this period were closed at exactly $50,000 with no line items, no stage progression, or marked as duplicates/not-ICP. These represent pipeline hygiene opportunities, not strategic losses. Examples: Adevinta ("Deal created without any activity"), Nium ("DUPLICATE"), Keralty ("Not ICP"), GRO ("Jacco Keynote / Not an Opp"). Consider a CRM cleanup initiative to improve forecasting accuracy.
$1.0M across 3 deals with active recovery paths:
• Darktrace ($500K) — Confirmed SPICED mid-year execution. Matt Kaminski actively working Salesforce partnership angle with SPICED-trained AI agents.
• Lambda Labs SOW 4 ($350K) — Rescoping to new project. Lambda targeting $1B ARR with cloud pivot.
• TD SYNNEX ($150K) — 3rd-party agent; potential need late Fall 2026.